Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 707

Results For "C"

9533 News Found

Daiichi Sankyo commits US $1 million humanitarian aid to Ukraine
Sustainability | March 11, 2022

Daiichi Sankyo commits US $1 million humanitarian aid to Ukraine

The money will be donated to the United Nations Children’s Fund (UNICEF)


Amity awards Dr Azad Moopen Doctorate for Philanthropy
Sustainability | March 11, 2022

Amity awards Dr Azad Moopen Doctorate for Philanthropy

Over the last 35 years, Dr. Moopen – Founder Chairman and Managing Director of Aster DM Healthcare has played a phenomenal role in strengthening the healthcare delivery system in GCC


Emmes acquires Casimir, its fourth major acquisition
Biotech | March 11, 2022

Emmes acquires Casimir, its fourth major acquisition

Casimir further differentiates Emmes’ industry-leading rare disease research capabilities


AbbVie’s Phase 3 data of Atogepant indicates positive outcome for migraine treatment
Biotech | March 11, 2022

AbbVie’s Phase 3 data of Atogepant indicates positive outcome for migraine treatment

Data from this study will support a submission to expand the use of atogepant to include preventive treatment of chronic migraine in the United States and additional submissions globally


Cancer surgeons gather in Delhi to learn new cancer therapies
Public Health | March 11, 2022

Cancer surgeons gather in Delhi to learn new cancer therapies

Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system


Strides receives USFDA approval for Colchicine tablets
Drug Approval | March 11, 2022

Strides receives USFDA approval for Colchicine tablets

Colchicine tablets are used for the treatment and prevention of gout. It reduces inflammation which causes pain, swelling and other symptoms of gout


Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals
interviews | March 10, 2022

Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals

As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma


Medical devices production under PLI scheme gets off the ground
News | March 10, 2022

Medical devices production under PLI scheme gets off the ground

A total of 21 applicants have been approved for 49 products, with the potential to utilize an incentive amount of Rs. 2541 crore


Gufic Biosciences collaborates with Selvax for cancer treatment
Biotech | March 10, 2022

Gufic Biosciences collaborates with Selvax for cancer treatment

Selvax's goal is to develop safe, effective and immunological-based treatments for a range of hard-to-treat solid tumours


Non-invasive leadless pacemaker implanted in a 60-year-old at Fortis Hospital, Malar
Hospitals | March 10, 2022

Non-invasive leadless pacemaker implanted in a 60-year-old at Fortis Hospital, Malar

The medical team led by Dr. Babu Ezhumalai implanted the dual-chamber leadless pacemaker through a non-surgical procedure successfully